RIL
ADPT icon

Rothschild Investment LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Rothschild Investment LLC’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
13,337
+37
+0.3% +$567 0.01% 771
2026
Q1 		$185K Buy
13,300
+7
+0.1% +$112 0.01% 697
2025
Q4 		$216K Buy
13,293
+3,013
+29% +$49.2K 0.01% 597
2025
Q3 		$154K Sell
10,280
-70
-0.7% -$853 0.01% 687
2025
Q2 		$121K Buy
10,350
+45
+0.4% +$409 0.01% 603
2025
Q1 		$76.6K Buy
10,305
+70
+0.7% +$538 0.01% 679
2024
Q4 		$61.4K Buy
10,235
+25
+0.2% +$138 ﹤0.01% 743
2024
Q3 		$52.3K Buy
10,210
+170
+2% +$741 ﹤0.01% 764
2024
Q2 		$36.3K Buy
10,040
+40
+0.4% +$127 ﹤0.01% 829
2024
Q1 		$32.1K Hold
10,000
– – ﹤0.01% 822
2023
Q4 		$49K Hold
10,000
– – ﹤0.01% 659
2023
Q3 		$55K Buy
+10,000
New +$66.1K ﹤0.01% 469
2021
Q4 		– Sell
-6,000
Closed -$204K – 502
2021
Q3 		$204K Buy
6,000
+1,000
+20% +$36.2K 0.02% 457
2021
Q2 		$204K Hold
5,000
– – 0.02% 460
2021
Q1 		$201K Buy
+5,000
New +$271K 0.02% 443
2020
Q4 		– Sell
-7,000
Closed -$340K – 453
2020
Q3 		$340K Buy
+7,000
New +$294K 0.04% 318

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rothschild Investment LLC's ADPT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Adaptive Biotechnologies (ADPT) stake by 0.28% in Q2 2026, buying an estimated $567 and bringing the position to 13,337 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #771.

Rothschild Investment LLC first reported a position in ADPT in Q3 2020 and has held it in 16 quarters since. The position peaked at $340K in Q3 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Rothschild Investment LLC held 13,337 shares of Adaptive Biotechnologies worth $286K as of Q2 2026.
  • Rothschild Investment LLC bought 37 Adaptive Biotechnologies shares in Q2 2026, an estimated $567.
  • Adaptive Biotechnologies made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #771 holding.
  • Rothschild Investment LLC first reported a position in Adaptive Biotechnologies in Q3 2020 and has held it in 16 quarters since.
  • Rothschild Investment LLC's Adaptive Biotechnologies position peaked at $340K in Q3 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.